As of 11:19am ET
| +0.52 / +2.02%|
The 8 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 21.00, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a -20.98% decrease from the last price of 26.58.
The current consensus among 9 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.